13.07.2015 Views

Official Proceedings - AIUM

Official Proceedings - AIUM

Official Proceedings - AIUM

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

American Institute of Ultrasound in Medicine <strong>Proceedings</strong> J Ultrasound Med 32(suppl):S1–S134, 2013surgery (MRgFUS) is a noninvasive treatment for symptomatic uterinefibroids. Patient selection is the most important step to achieve good results.The purpose of this study was to assess the initial efficacy of scaledsignal intensity (SSI) of uterine fibroids on T2-weighted MR images as anew objective parameter to determine the suitability for MRgFUS.Methods—Twenty-four uterine fibroids in 20 premenopausalwomen were treated using MRgFUS. Treatments were performed fromOctober 2008 to January 2010, and the mean age of the patients was 37.9± 5.9 years. SSI was measured on T2-weighted MR images by standardizingits mean pixel intensity to a 0 to 100 scale, using reference intensitiesof muscle (0) and fat (100), respectively. SSI in each fibroid was retrospectivelyanalyzed according to the nonperfusion volume (NPV) ratio.Results—The mean NPV ratio in uterine fibroids with SSI 10 (n= 18), the mean NPV ratio was 51.8% ± 21.0%. Uterine fibroids with SSI10.Conclusions—SSI of uterine fibroids on T2-weighted MR imagescan be suggested as an objective parameter for patient selection inMRgFUS. Uterine fibroids with

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!